Taro Pharmaceutical Indus... (TARO)
NYSE: TARO
· Real-Time Price · USD
42.98
0.01 (0.02%)
At close: Jun 21, 2024, 9:59 PM
Taro Pharmaceutical Industries Cash Flow Statement
Financials in USD. Fiscal
year is
April - March.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 |
Net Income | 15.08M | 20.21M | 8.55M | 10.03M | 6.91M | 7.27M | -2.81M | 14.08M | 27.4M | 26.31M | 23.32M | -18.77M | -28.88M | 33.04M | 45.06M | -449.96M |
Depreciation & Amortization | 8.22M | 7.37M | 7.61M | 7.89M | 10.81M | 7.33M | 7.02M | 6.98M | 6.67M | 6.45M | 6.45M | 6.35M | 6.34M | 5.98M | 5.79M | 5.57M |
Stock-Based Compensation | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | -2.64M | 7.48M | 10.01M | 505K | -65.52M | 237.67K | 5.67M | -61.51M | 252.44M | -197.06M | -112.07M | 48.39M | 72.92M | -5.8M | -81.42M | 479.19M |
Other Non-Cash Items | -9.61M | -3.94M | 1.05M | -3.68M | -13.53M | 8.32M | 3.6M | 4.67M | 5.24M | 1.79M | 4.51M | 1.42M | 2.68M | 1.41M | -1.1M | -2.4M |
Deferred Income Tax | 14.38M | 2.65M | 160K | 2.38M | 12.19M | 2.37M | -170K | 2.42M | 8.2M | -1.92M | 5.68M | 11.24M | -6.54M | 7.71M | -37.22M | -2.37M |
Change in Working Capital | 3.24M | 4.64M | 30.15M | -8.85M | 40.27M | -4.73M | 12.73M | -86.17M | -6.25M | -224.57M | -91.97M | 43.75M | 77.45M | -5.27M | -124.78M | 513.27M |
Operating Cash Flow | 44.24M | 30.93M | 47.52M | 7.78M | 56.65M | 12.77M | 20.36M | -58.03M | 41.26M | -191.93M | -52.02M | 43.99M | 51.05M | 42.86M | -112.26M | 64.11M |
Capital Expenditures | -7.95M | -34.48M | -7.01M | -6.84M | -8.54M | -7.8M | -1.4M | -2.11M | -2.8M | -3.3M | -2.01M | -3.93M | -2.82M | -5.3M | -3.83M | -5.2M |
Cash Acquisitions | n/a | n/a | -1K | n/a | 172K | 88.39M | 69.42M | -36.83M | -91.87M | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.52M | n/a | 31.86M | -31.86M | -848.17M | -75.94M | -47.97M | -73K | -13.94M | -10.72M | -29.52M | -12.5M | n/a | n/a | n/a | -40.83M |
Sales Maturities Of Investments | -42.85M | 116.15M | 73.72M | n/a | 863.39M | -12.46M | -21.42M | 36.94M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -51.45M | 116.1M | 1K | -31.91M | -172K | -88.39M | -69.42M | 36.83M | -91.87M | -10.73M | -29.55M | -12.57M | 24.76M | 18.3M | 82.64M | -40.89M |
Investing Cash Flow | -52.32M | 81.67M | 98.57M | -38.7M | 6.67M | -96.19M | -70.79M | 34.76M | -108.61M | -14.02M | -31.53M | -16.43M | 21.95M | 13M | 78.81M | -46.02M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.62M | -18.32M | -20.95M | -3.24M | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.32M | n/a | n/a | -6.62M | -18.32M | -20.95M | -3.24M | n/a | n/a |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -18.32M | n/a | n/a | -6.62M | -18.32M | -20.95M | -3.24M | n/a | n/a |
Net Cash Flow | -19.5M | 113.4M | 144.85M | -30.33M | 62.52M | -83.22M | -50.61M | -25.33M | -66.97M | -205.56M | -91.22M | 9.71M | 52.26M | 54.12M | -33.25M | 18.69M |
Free Cash Flow | 36.3M | -3.55M | 40.51M | 933K | 48.11M | 4.97M | 18.96M | -60.14M | 38.46M | -195.24M | -54.03M | 40.07M | 48.24M | 37.56M | -116.09M | 58.91M |